Live Breaking News & Updates on Cardiology Heart Failure Congress

Stay updated with breaking news from Cardiology heart failure congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioCardia Reports First Quarter 2024 Business Highlights and Financial Results

SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for th. ....

United States , Peter Altman , Biocardia Inc , Maryland Stem Cell Research Fund , European Society Of Cardiology Heart Failure Congress , Medicaid Services , Exchange Commission , Device Agency , Company Annual Report On Form , Exchange Commission On , Cell Therapy , Ischemic Heart Failure , Failure Trial , Heart Failure Therapeutics , Therapy Heart Failure , Chronic Myocardial Ischemia , Therapy Chronic Myocardial Ischemia Trial , Excellent Phase , European Society , Cardiology Heart Failure Congress , Therapy Heart Failure Trial , Reduced Ejection Fraction , Mesenchymal Stem Cell Therapy , Therapy Trial , Heart Failure , Medical Device Agency ,

BioCardia : Reports First Quarter 2024 Business Highlights and Financial Results

BioCardia : Reports First Quarter 2024 Business Highlights and Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Peter Altman , European Society Of Cardiology Heart Failure Congress , Biocardia Inc , Exchange Commission On , Medicaid Services , Exchange Commission , Maryland Stem Cell Research Fund , Device Agency , Biocardia Reports First Quarter , Financial Results , Cell Therapy , Ischemic Heart Failure , Failure Trial , Heart Failure Therapeutics , Therapy Heart Failure , Chronic Myocardial Ischemia , Therapy Chronic Myocardial Ischemia Trial , Excellent Phase , European Society , Cardiology Heart Failure Congress , Therapy Heart Failure Trial , Reduced Ejection Fraction , Mesenchymal Stem Cell Therapy , Morph Access Innovations Business , Therapy Trial ,

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

In what might prove the swan song for ERAs in HF, SERENADE tried to exclude patients with fluid retention to no avail. ....

Northwestern University , United States , San Francisco , Adriaan Voors , Sanjiv Shah , John Teerlink , University Of California , Md Northwestern University , Md San Francisco Va Medical Center , Phd University Of Groningen , European Society Of Cardiology Heart Failure Congress , European Society , Cardiology Heart Failure Congress ,